British Patient Capital Commits $50.8 Million to Evolution Equity Partners’ Cybersecurity Fund, Boosting UK’s Cybersecurity Ecosystem

Evolution Equity Partners has received a $50.8 million commitment from British Patient Capital for their third fund, which specializes in investing in cybersecurity and enterprise software companies. This investment follows a previous $35 million commitment to Evolution’s second fund in 2020.

British Patient Capital’s investment in Evolution Equity Partners highlights the growing importance of cybersecurity as businesses strive to protect themselves, their customers, and their products. The UK has emerged as a global leader in cybersecurity innovation and expertise, making it an attractive destination for investors looking to invest in this valuable technology.

Richard Seewald, Founder and Managing Partner of Evolution Equity Partners, expressed excitement about partnering with British Patient Capital and NSSIF to support UK-based cybersecurity companies with capital. He emphasized the importance of next-generation technology that defends and protects society and our way of life in the current environment.

Investment Director of Funds at British Patient Capital, Robert Greenwood, highlighted the evolution of cybersecurity from a niche subsector to a key application across all sectors. He underscored the need for continued investment in this area to support UK-based businesses as they navigate the ever-changing landscape of cyber threats.